Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment

Human Reproduction

Volumn 27, Issue 2, 2012, Pages 444-450

  Custers, Inge M ^a   Van Rumste, Minouche M E ^b   Van Der Steeg, Jan Willem ^a   Van Wely, Madelon ^a   Hompes, Peter G A ^c   Bossuyt, Patrick ^a   Broekmans, Frank J ^d   Renckens, Cees N M ^e   Eijkemans, Marinus J C ^d   Van Dessel, Thierry J H M ^f   Van Der Veen, Fulco ^a   Mol, Ben W J ^b   Steures, Pieternel ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Westfries Gasthuis ^*  (Netherlands)

^f CPRLab   (Netherlands)

Author keywords

economic analysis; expectant management; intrauterine insemination and controlled ovarian stimulation; long term outcome; unexplained subfertility

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONCEPTION; CONTROLLED OVARY STIMULATION; CONTROLLED STUDY; COST CONTROL; DRUG COST; ECTOPIC PREGNANCY; EXPECTANT MANAGEMENT; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HEALTH CARE COST; HOSPITAL COST; HUMAN; INTENTION TO TREAT ANALYSIS; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MEDICAL FEE; MULTICENTER STUDY; MULTIPLE PREGNANCY; NETHERLANDS; OUTCOME ASSESSMENT; OVULATION INDUCTION; PREGNANCY RATE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; SUBFERTILITY; WATCHFUL WAITING;

EID: 84855902195     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der389     Document Type: Article

References (19)

1. Andersen AN, Goossens V, Ferraretti AP, Bhattacharya S, Felberbaum R, de Mouzon J, Nygren KG; European IVF-monitoring (EIM) Consortium; European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 2008;23:756-771.
2. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application ofthe non-parametricbootstrap. Stat Med 2000;19:3219-3236.
3. Cantineau AE, Cohlen BJ, Heineman MJ. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with sub fertility (Review). Cochrane Database Syst Rev 2007;18:CD005356.
4. Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod 2007;22:792-797.
5. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford University Press, 1987.
6. Dutch Society of Obstetrics and Gynaecology. http://nvog-documenten. nl.
7. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update 2009;15:265-277.
8. Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365:1807-1816.
9. http://ctg.bit-ic.nl/Nzatarieven/top. do.
10. Hunault CC, Habbema JD, Eijkemans MJ, Collins JA, Evers JL, te Velde ER. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod 2004;19:2019-2026.
11. Merkus JM. Fertility treatments: possibilities for fewer multiple births and lower costs-the 'Umbrella' study. Ned Tijdschr Geneeskd 2006;150:1162-1164.
12. Nixon J, Rice S, Drummond M, Boulenger S, Ulmann P, de Pouvourville G. Guidelines for completing the EURONHEED transferability information checklists. Eur J Health Econ 2009;10:157-165.
13. Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010;94:888-899.
14. Steures P, van der Steeg JW, Hompes PG, Habbema JD, Eijkemans MJ, Broekmans FJ, Verhoeve HR, Bossuyt PM, van der Veen F, Mol BW for the Collaborative Effort on the Clinical Evaluation in Reproductive Medicine. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomized clinical trial. Lancet 2006;368:216-221.
15. Steures P, van der Steeg JW, Hompes PG, van der Veen F, Mol BW. Intrauterine insemination in The Netherlands. Reprod Biomed Online 2007;14:110-116.
16. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Broekmans FJ, van Dessel HJ, Bossuyt PM, van der Veen F, Mol BW for the CECERM study group (Collaborative Effort for Clinical Evaluation in Reproductive Medicine). Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod 2007;22:536-542.
17. van Rumste MM, Custers IM, van der Veen F, van Wely M, Evers JL, Mol BW. The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update 2008;14:563-570.
18. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR, McNei BJ. Clinical Decision Analysis. Philadelphia: WB Saunders, 1980.
19. Wordsworth S, Buchanan J, Mollison J, Harrild K, Robertson L, Tay C, Harrold A, McQueen D, Lyall H, Johnston L et al. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? Hum Reprod 2011;26:369-375.